HOUSTON--(BUSINESS WIRE)--Apr 24, 2012-- Quantum International Corp.

(OTCBB: QUAN) announced today that the company is targeting incredible new advances in robotics that are changing the way doctors treat some cancers.

Many forms of the disease, including gynecologic cancers, can be extremely difficult to diagnose and treat without large incisions with long recovery times. New robotic tools are helping to make the process far less invasive.

Small robotic tools can translate a surgeon's movements into miniscule motion. Instead of a large incision of traditional abdominal surgery, those facing a diagnosis of gynecological cancer need only a few tiny incisions, the size of a large pencil-just enough room for the arms of a remote-controlled robot, instead of the surgeon's actual hands, to find and remove possible cancer from the uterus, cervix or ovaries.

Instead of debilitating pain and significant recovery time, patients need only an overnight stay and Ibuprofen. Outcomes of these surgeries can be improved, as well.

Doctors are seeing such positive results in cancer patients that many expect the future of all such surgeries to be done this less-invasive way. Quantum International is working to help bring more robotics innovations to the market capable of improving healthcare worldwide.

As of 2010, only 1,752 robotic surgical systems have been installed globally. QUAN's aggressive new initiative could lead to more advancements in this sector, as surgeons seek out newer, more affordable ways to perform complex medical procedures. As more and more advanced and impressive surgical robots are developed, the market for these devices could be set to explode.

The company plans to announce its initial business targets in the red-hot robotics space soon. For more information on Quantum International's robotics initiatives, please visit

Quantum International Corp. is working to develop the next generation of robotics technology to compete in a booming global industry alongside Hansen Medical, Inc. (Nasdaq: HNSN), MAKO Surgical Corp.

(Nasdaq: MAKO), Covidien (NYSE: COV), Varian Medical Systems Inc.

(VAR), and Accuray Incorporated (Nasdaq: ARAY).

About QUAN International Corp.

Quantum International Corp. (OTCBB: QUAN) is an emerging robotics innovation company working to commercialize the next generation of sophisticated, automated technology. The Company is positioning itself to develop, deliver and market the most cutting-edge innovations in robotics in order to leverage the worldwide demand for the precision, speed, and cost-effectiveness these technologies offer.

For more information about Quantum International Corp., please visit

Notice Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

CONTACT: Quantum International Corporation Robert Federowicz, 832-308-1260 President and CEO KEYWORD: UNITED STATES NORTH AMERICA TEXAS INDUSTRY KEYWORD: SURGERY TECHNOLOGY HARDWARE HEALTH MEDICAL DEVICES ONCOLOGY SOURCE: Quantum International Corporation Copyright Business Wire 2012 PUB: 04/24/2012 05:00 AM/DISC: 04/24/2012 05:00 AM